• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Pegaspargase, venetoclax, and nelarabine: a successful bridge to allogeneic hematopoietic stem cell transplantation in a relapsed/refractory T-cell acute lymphoblastic leukemia patient.

作者信息

Yiğit Kaya Süreyya, Bektas Sebnem, Askin Abdullah Emre, Balık Aydın Berrin, Mutlu Yaşa Gül, Sevindik Ömür Gökmen

机构信息

Department of Hematology, Faculty of Medicine, Istanbul Medipol University, Istanbul, Turkey.

Faculty of Medicine, Istanbul Medipol University, Istanbul, Turkey.

出版信息

Ann Hematol. 2023 Jun;102(6):1599-1600. doi: 10.1007/s00277-023-05231-4. Epub 2023 Apr 26.

DOI:10.1007/s00277-023-05231-4
PMID:37099080
Abstract
摘要

相似文献

1
Pegaspargase, venetoclax, and nelarabine: a successful bridge to allogeneic hematopoietic stem cell transplantation in a relapsed/refractory T-cell acute lymphoblastic leukemia patient.培门冬酶、维奈克拉和奈拉滨：一名复发/难治性T细胞急性淋巴细胞白血病患者成功过渡到异基因造血干细胞移植的桥梁。
Ann Hematol. 2023 Jun;102(6):1599-1600. doi: 10.1007/s00277-023-05231-4. Epub 2023 Apr 26.
2
Nelarabine-containing regimen followed by daratumumab as an effective salvage therapy and bridge to allogeneic hematopoietic stem cell transplantation for primary refractory early T-cell precursor lymphoblastic leukemia.含奈拉滨方案后使用达雷妥尤单抗作为原发性难治性早期T细胞前体淋巴细胞白血病的有效挽救疗法及异基因造血干细胞移植的桥梁。
Leuk Lymphoma. 2021 Sep;62(9):2295-2297. doi: 10.1080/10428194.2021.1901097. Epub 2021 Mar 21.
3
Safety of nelarabine in adults with relapsed or refractory T-cell acute lymphoblastic leukemia/lymphoma.纳拉滨治疗成人复发或难治性 T 细胞急性淋巴细胞白血病/淋巴瘤的安全性。
Expert Opin Drug Saf. 2021 Jul;20(7):751-756. doi: 10.1080/14740338.2021.1919621. Epub 2021 May 17.
4
The role of nelarabine in the treatment of T-cell acute lymphoblastic leukemia: literature review and own experience.奈拉滨在治疗T细胞急性淋巴细胞白血病中的作用：文献综述及自身经验
Ter Arkh. 2018 Aug 17;90(7):38-50. doi: 10.26442/terarkh201890738-50.
5
Therapeutic strategies, including allogeneic stem cell transplantation, to overcome relapsed/refractory adult T-cell acute lymphoblastic leukemia.克服复发/难治性成人 T 细胞急性淋巴细胞白血病的治疗策略，包括异基因干细胞移植。
Expert Rev Hematol. 2021 Aug;14(8):765-775. doi: 10.1080/17474086.2021.1960817. Epub 2021 Aug 9.
6
Efficacy and safety of nelarabine in patients with relapsed or refractory T-cell acute lymphoblastic leukemia: a systematic review and meta-analysis.尼拉滨治疗复发或难治性 T 细胞急性淋巴细胞白血病患者的疗效和安全性：系统评价和荟萃分析。
Ann Hematol. 2022 Aug;101(8):1655-1666. doi: 10.1007/s00277-022-04880-1. Epub 2022 Jun 21.
7
Nelarabine as salvage therapy and bridge to allogeneic stem cell transplant in 118 adult patients with relapsed/refractory T-cell acute lymphoblastic leukemia/lymphoma. A CAMPUS ALL study.在 118 例复发/难治性 T 细胞急性淋巴细胞白血病/淋巴瘤成人患者中，用奈拉滨作为挽救性治疗和异基因干细胞移植的桥接治疗。CAMPUS ALL 研究。
Am J Hematol. 2020 Dec;95(12):1466-1472. doi: 10.1002/ajh.25957. Epub 2020 Aug 31.
8
Donor-Derived CD7 CAR-T Therapy Followed by Allogeneic Hematopoietic Stem Cell Transplantation for Acute T-Lymphocytic Leukemia Associated With Hepatitis B: A Case Report.供体来源 CD7 CAR-T 治疗联合异基因造血干细胞移植治疗乙型肝炎相关急性 T 淋巴细胞白血病：一例报告。
Front Immunol. 2022 Jul 12;13:931452. doi: 10.3389/fimmu.2022.931452. eCollection 2022.
9
CAR-T cells and allogeneic hematopoietic stem cell transplantation for relapsed/refractory B-cell acute lymphoblastic leukemia.嵌合抗原受体T细胞（CAR-T）与异基因造血干细胞移植治疗复发/难治性B细胞急性淋巴细胞白血病
Immunotherapy. 2017 Oct;9(13):1115-1125. doi: 10.2217/imt-2017-0072.
10
Nelarabine for the treatment of patients with relapsed or refractory T-cell acute lymphoblastic leukemia or lymphoblastic lymphoma.纳拉滨用于治疗复发或难治性 T 细胞急性淋巴细胞白血病或淋巴母细胞淋巴瘤的患者。
Hematol Oncol Clin North Am. 2009 Oct;23(5):1121-35, vii-viii. doi: 10.1016/j.hoc.2009.07.008.

引用本文的文献

1
Combination of venetoclax with CHG regimen in refractory/relapsed T-lymphoblastic lymphoma/acute lymphoblastic leukemia: a case series and literature review.维奈托克与CHG方案联合治疗难治性/复发性T淋巴细胞淋巴瘤/急性淋巴细胞白血病：病例系列及文献综述
Discov Oncol. 2025 Jul 1;16(1):1202. doi: 10.1007/s12672-025-03055-4.

本文引用的文献

1
Efficacy and safety of nelarabine in patients with relapsed or refractory T-cell acute lymphoblastic leukemia: a systematic review and meta-analysis.尼拉滨治疗复发或难治性 T 细胞急性淋巴细胞白血病患者的疗效和安全性：系统评价和荟萃分析。
Ann Hematol. 2022 Aug;101(8):1655-1666. doi: 10.1007/s00277-022-04880-1. Epub 2022 Jun 21.
2
Venetoclax combined with azacitidine as an effective and safe salvage regimen for relapsed or refractory T-cell acute lymphoblastic leukemia: a case series.维奈托克联合阿扎胞苷作为复发或难治性T细胞急性淋巴细胞白血病的一种有效且安全的挽救方案：病例系列
Leuk Lymphoma. 2021 Dec;62(13):3300-3303. doi: 10.1080/10428194.2021.1957876. Epub 2021 Jul 29.
3
Therapeutic strategies, including allogeneic stem cell transplantation, to overcome relapsed/refractory adult T-cell acute lymphoblastic leukemia.
克服复发/难治性成人 T 细胞急性淋巴细胞白血病的治疗策略，包括异基因干细胞移植。
Expert Rev Hematol. 2021 Aug;14(8):765-775. doi: 10.1080/17474086.2021.1960817. Epub 2021 Aug 9.
4
Safety of nelarabine in adults with relapsed or refractory T-cell acute lymphoblastic leukemia/lymphoma.纳拉滨治疗成人复发或难治性 T 细胞急性淋巴细胞白血病/淋巴瘤的安全性。
Expert Opin Drug Saf. 2021 Jul;20(7):751-756. doi: 10.1080/14740338.2021.1919621. Epub 2021 May 17.
5
Nelarabine as salvage therapy and bridge to allogeneic stem cell transplant in 118 adult patients with relapsed/refractory T-cell acute lymphoblastic leukemia/lymphoma. A CAMPUS ALL study.在 118 例复发/难治性 T 细胞急性淋巴细胞白血病/淋巴瘤成人患者中，用奈拉滨作为挽救性治疗和异基因干细胞移植的桥接治疗。CAMPUS ALL 研究。
Am J Hematol. 2020 Dec;95(12):1466-1472. doi: 10.1002/ajh.25957. Epub 2020 Aug 31.
6
Relapsed/Refractory ETP-ALL Successfully Treated With Venetoclax and Nelarabine as a Bridge to Allogeneic Stem Cell Transplant.复发/难治性早期T细胞前体急性淋巴细胞白血病经维奈克拉和奈拉滨成功治疗作为异基因干细胞移植的桥梁
Hemasphere. 2020 Jun 8;4(3):e379. doi: 10.1097/HS9.0000000000000379. eCollection 2020 Jun.
7
Venetoclax and decitabine for treatment of relapsed T-cell acute lymphoblastic leukemia: A case report and review of literature.维奈托克联合地西他滨治疗复发 T 细胞急性淋巴细胞白血病：病例报告及文献复习。
Hematol Oncol Stem Cell Ther. 2021 Sep;14(3):246-251. doi: 10.1016/j.hemonc.2019.10.002. Epub 2020 Mar 19.
8
Clinical Experience With Venetoclax Combined With Chemotherapy for Relapsed or Refractory T-Cell Acute Lymphoblastic Leukemia. Venetoclax 联合化疗治疗复发或难治性 T 细胞急性淋巴细胞白血病的临床经验。
Clin Lymphoma Myeloma Leuk. 2020 Apr;20(4):212-218. doi: 10.1016/j.clml.2019.09.608. Epub 2019 Sep 30.
9
Pegaspargase: A Review in Acute Lymphoblastic Leukaemia.培门冬酶：急性淋巴细胞白血病治疗中的应用评价。
Drugs. 2019 May;79(7):767-777. doi: 10.1007/s40265-019-01120-1.
10
Management of adults with T-cell lymphoblastic leukemia.成人 T 细胞淋巴母细胞白血病的治疗。
Blood. 2017 Mar 2;129(9):1134-1142. doi: 10.1182/blood-2016-07-692608. Epub 2017 Jan 23.